Nigeria is set to introduce lenacapavir, a twice-yearly injectable drug for HIV prevention, in March 2026. Health experts say the injection could revolutionize HIV prevention, offering a more convenient and discreet alternative to daily oral PrEP for people at high risk of infection. Lenacapavir is a long-acting antiretroviral that targets the HIV capsid, preventing the …